Standout Papers
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial (2020)
- Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials (2021)
Immediate Impact
1 by Nobel laureates 4 from Science/Nature 63 standout
Citing Papers
Complement in breast milk modifies offspring gut microbiota to promote infant health
2024 Standout
From periphery to center stage: 50 years of advancements in innate immunity
2024 Standout
Works of Kai Chu being referenced
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
2020 Standout
Effect of maternal antibody on the infant immune response to inactivated poliovirus vaccines made from Sabin strains
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Kai Chu | 1386 | 272 | 248 | 406 | 47 | 1.8k | |
| Hongxing Pan | 1320 | 410 | 87 | 481 | 35 | 1.7k | |
| Weidong Yin | 1748 | 289 | 638 | 474 | 30 | 2.4k | |
| Youngmee Jee | 1042 | 563 | 383 | 169 | 81 | 1.8k | |
| Chee Wah Tan | 2441 | 314 | 389 | 197 | 59 | 3.0k | |
| Thomas Tran | 971 | 802 | 173 | 125 | 50 | 1.9k | |
| Miao Xu | 2073 | 376 | 554 | 284 | 68 | 2.8k | |
| Bettina Bankamp | 1124 | 1535 | 137 | 304 | 45 | 2.2k | |
| Harry F. Hull | 838 | 828 | 415 | 314 | 58 | 2.0k | |
| Changgui Li | 1683 | 1244 | 247 | 517 | 99 | 2.9k | |
| Mark A. Katz | 1622 | 939 | 129 | 796 | 75 | 2.9k |
All Works
Loading papers...